Pfizer News and Research

RSS
QIAGEN receives first companion diagnostic approval in Japan

QIAGEN receives first companion diagnostic approval in Japan

CytoReason enters into drug discovery collaboration agreement with Pfizer

CytoReason enters into drug discovery collaboration agreement with Pfizer

Researchers design new questionnaire to improve knowledge of impact of menopause on women

Researchers design new questionnaire to improve knowledge of impact of menopause on women

Yale researchers use arthritis medication to treat patient with disfiguring sarcoidosis

Yale researchers use arthritis medication to treat patient with disfiguring sarcoidosis

Black women with breast cancer have worse outcomes despite receiving equivalent treatments as white women

Black women with breast cancer have worse outcomes despite receiving equivalent treatments as white women

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

FDA approves new treatment for AML patients

FDA approves new treatment for AML patients

Automating Data Capture and Image Analysis in Continuous Experiments

Automating Data Capture and Image Analysis in Continuous Experiments

Survey: Majority of Americans are concerned about health threat posed by antibiotic resistance

Survey: Majority of Americans are concerned about health threat posed by antibiotic resistance

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Novel drug extends survival for women with HR-positive metastatic breast cancer

Novel drug extends survival for women with HR-positive metastatic breast cancer

Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy

Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy

Drugs approved for breast cancer treatment are effective and well tolerated in men

Drugs approved for breast cancer treatment are effective and well tolerated in men

Study: Targeting specific genomic mutation in breast cancer improves survival

Study: Targeting specific genomic mutation in breast cancer improves survival

Targeted drug and hormone therapy combination extends breast cancer survival

Targeted drug and hormone therapy combination extends breast cancer survival

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Prostate radiotherapy improves survival in men with low burden of metastatic disease

Prostate radiotherapy improves survival in men with low burden of metastatic disease

Study highlights existence of barriers to early clinical trial access for adolescents and young adults

Study highlights existence of barriers to early clinical trial access for adolescents and young adults